눈 건강 제품 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Eye Health Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 6,879,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,046,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,699,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

주요 인사이트

• 눈 건강 제품 시장 규모 : 30억 1,940만 달러(2025년)
• 예상 시장 규모 : 50억 930만 달러(2032년)
• 세계 시장 성장률 : 7.50%(2025-2032년 CAGR)

눈 건강 제품 시장 - 보고서 범위

눈 건강 제품 시장에는 시력 개선 및 안과 관련 질환의 예방을 목적으로 하는 영양 보충제 및 특수 제제가 포함됩니다. 이러한 제품에는 루테인, 제아잔틴, 오메가 3 지방산, 항산화제, 플라보노이드와 같은 필수 영양소가 함유되어 있어 눈의 기능과 전반적인 건강에 도움을 줍니다. 시력 관리에 대한 인식 증가, 안질환 유병률 증가, 예방적 의료 솔루션에 대한 소비자 수요 증가로 인해 시장이 확대되고 있습니다.

시장 성장 촉진요인

노화성 황반변성(AMD), 백내장, 안구건조증 발병률 증가 등 여러 요인이 세계 눈 건강 제품 시장의 성장을 촉진하고 있습니다. 디지털 기기 사용으로 인한 스크린 사용 시간의 증가는 시력 관련 문제의 증가로 이어져 눈 건강보조제에 대한 수요를 촉진하고 있습니다. 또한, 영양 연구의 발전과 노령 인구의 증가는 시장 성장을 더욱 촉진하고 있습니다. 눈 건강을 위한 종합비타민 블렌드와 같은 혁신적인 제형의 가용성 또한 제품 채택을 촉진하고 있습니다.

시장 억제요인

눈 건강 제품 시장은 큰 성장 잠재력에도 불구하고, 높은 제품 비용과 개발도상국 시장에서의 낮은 인지도와 같은 도전에 직면해 있습니다. 또한, 건강기능식품의 제법이 표준화되지 않은 점과 건강 효능 표시와 관련된 규제 문제도 시장 확대에 걸림돌이 될 수 있습니다. 또한, 처방약이나 외과적 개입과 같은 대체 치료법의 존재는 눈 건강보조식품에 대한 경쟁적 도전이 될 수 있습니다.

시장 기회

눈 건강 제품 시장은 천연 소재 및 식물성 보충제에 대한 수요 증가로 인해 큰 성장 기회를 제공하고 있습니다. 맞춤형 영양과 디지털 건강 솔루션의 통합으로 제품 효능과 소비자 참여도가 높아질 것으로 예상됩니다. 또한, 의료진, 안과 의사, E-Commerce 플랫폼과의 전략적 파트너십은 시장 침투를 촉진할 수 있습니다. 특히 신흥 경제권에서의 유통망 확대는 시장 성장에 더욱 기여할 것으로 보입니다.

이 보고서는 세계 눈 건강 제품 시장을 조사하여 성장 촉진요인, 동향, 기회, 과제 등 시장 역학에 대한 상세한 분석을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품의 혁신/개발 동향

제4장 중요한 성공요인

• 제품 채용률 - 주요 통계
• 규제 시나리오
• 질병 역학
• 제품 USP 분석
• PESTEL 분석
• Porters 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 성분별
  • 적응증별
  • 형상별
  • 지역별
• 시장 시나리오(2021년)

제7장 세계의 눈 건강 제품 시장 수요 전망(2019-2032년)

• 시장 금액 실적 분석(2019-2024년)
• 현재와 향후 시장 금액 분석과 예측(2025-2032년)
  • 전년비 성장 동향 분석
  • 절대적 수익 기회 분석

제8장 세계의 눈 건강 제품 시장 전망(2019-2032년)

• 소개/주요 조사 결과
• 시장 규모 실적 분석 : 성분별(2019-2024년)
• 현재와 향후 시장 규모 분석과 예측 : 성분별(2025-2032년)
  • 루테인, 제아잔틴
  • 항산화물질
  • 오메가 3 지방산
  • 코엔자임 Q10
  • 플라보노이드
  • 아스타잔틴
  • 알파리포산
  • 기타 성분
• 시장 매력 분석 : 원료별

제9장 세계의 눈 건강 제품 시장 전망(2019-2032년)

• 소개/주요 조사 결과
• 시장 규모 실적 분석 : 적응증별(2019-2024년)
• 현재와 향후 시장 규모 분석과 예측 : 적응증별(2025-2032년)
  • 노인황반변성(AMD)
  • 백내장
  • 안구건조증
  • 기타 적응증
• 시장 매력 분석 : 적응증별

제10장 세계의 눈 건강 제품 시장 전망(2019-2032년)

• 소개/주요 조사 결과
• 시장 규모 실적 분석 : 형상별(2019-2024년)
• 현재와 향후 시장 규모 분석과 예측 : 형상별(2025-2032년)
  • 정제
  • 캡슐
  • 기타
• 시장 매력 분석 : 형상별

제11장 세계의 눈 건강 제품 시장 전망(2019-2032년)

• 소개
• 시장 규모 실적 분석 : 지역별(2019-2024년)
• 현재와 향후 시장 금액 분석과 예측(2025-2032년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장 매력 분석 : 지역별

제12장 북미의 눈 건강 제품 시장 전망(2019-2032년)

제13장 라텐아메리카눈 건강 제품 시장 전망(2019-2032년)

제14장 유럽의 눈 건강 제품 시장 전망(2019-2032년)

제15장 동아시아의 눈 건강 제품 시장 전망(2019-2032년)

제16장 남아시아의 눈 건강 제품 시장 전망(2019-2032년)

제17장 오세아니아눈 건강 제품 시장 전망(2019-2032년)

제18장 중동 및 아프리카의 눈 건강 제품 시장 전망(2019-2032년)

제19장 시장 구조 분석

• 시장 분석 : 기업 Tier별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제20장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마크
• 경쟁 상세
  • Pfizer Inc.
  • The Nature's Bounty Co.
  • Amway International
  • Bausch+Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.

제21장 사용되는 가정과 두문자어

제22장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Eye Health Products Market, providing an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges. This report offers valuable insights into the market structure, equipping stakeholders with the knowledge needed to make strategic decisions.

Key Insights:

• Eye Health Products Market Size (2025E): USD 3,019.40 Mn
• Projected Market Value (2032F): USD 5,009.30 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 7.50%

Eye Health Products Market - Report Scope:

The Eye Health Products Market includes dietary supplements and specialized formulations aimed at improving vision and preventing eye-related disorders. These products contain essential nutrients such as lutein, zeaxanthin, omega-3 fatty acids, antioxidants, and flavonoids, which support eye function and overall ocular health. The market is expanding due to increasing awareness about vision care, the rising prevalence of eye disorders, and growing consumer demand for preventive healthcare solutions.

Market Growth Drivers:

Several factors are fueling the growth of the global Eye Health Products Market, including the rising incidence of age-related macular degeneration (AMD), cataracts, and dry eye syndrome. Growing screen time due to digital device usage has led to an increase in vision-related issues, driving demand for eye health supplements. Additionally, advancements in nutritional research, coupled with the expanding geriatric population, are further propelling market growth. The availability of innovative formulations, such as multivitamin blends for eye health, is also enhancing product adoption.

Market Restraints:

Despite strong growth potential, the Eye Health Products Market faces challenges such as high product costs and limited awareness in developing regions. The lack of standardization in supplement formulations and regulatory challenges related to claims of health benefits may also hinder market expansion. Additionally, the presence of alternative treatment methods, such as prescription medications and surgical interventions, could pose a competitive challenge to eye health supplements.

Market Opportunities:

The Eye Health Products Market presents significant opportunities for growth due to increasing demand for natural and plant-based supplements. The integration of personalized nutrition and digital health solutions is expected to enhance product effectiveness and consumer engagement. Additionally, strategic partnerships with healthcare professionals, ophthalmologists, and e-commerce platforms can drive market penetration. Expanding distribution networks, particularly in emerging economies, will further contribute to market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the Eye Health Products Market?
• Which ingredients and formulations are gaining the most traction in the eye health industry?
• How is digitalization and increased screen exposure impacting market trends?
• Who are the major players in the Eye Health Products Market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future outlooks for the global Eye Health Products Market?

Competitive Intelligence and Business Strategy:

Leading companies in the Eye Health Products Market, including The Nature's Bounty Co., Pfizer Inc., Amway International, and Bausch + Lomb, are focusing on product innovation, clinical research, and strategic collaborations to strengthen their market position. Companies are investing in scientific advancements to develop high-potency supplements with enhanced bioavailability. E-commerce expansion, digital marketing strategies, and retail partnerships are also being leveraged to improve consumer outreach. The focus on sustainability and clean-label products is becoming a key differentiator in the competitive landscape.

Key Companies Profiled:

• The Nature's Bounty Co.
• Pfizer Inc.
• Amway International
• Bausch + Lomb
• Nutrivein
• ZeaVision LLC
• Kemin Industries, Inc.
• EyeScience
• Nutrachamps
• Bausch Health Companies Inc.
• Vitabiotics Ltd.

Eye Health Products Industry Research by Category:

By Ingredient:

• Lutein and Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Astaxanthin
• Alpha-Lipoic Acid
• Other Ingredients

By Indication:

• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Other Indications

By Form:

• Tablet
• Capsule
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmaps
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Rate - Key Statistics
• 4.2. Regulatory Scenario
• 4.3. Disease Epidemiology
• 4.4. Product USP Analysis
• 4.5. PESTEL Analysis
• 4.6. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Eye Care Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Prevalence of Eye Disorders
  • 5.2.2. Growing Awareness of Eye Diseases
  • 5.2.3. Rising Demand of Eye Health Products Amongst Millennials
  • 5.2.4. Advertisement from Manufacturers
  • 5.2.5. Mergers and Acquisitions
  • 5.2.6. Prevalence of AMD in Elderly Population
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Ingredient
  • 6.1.2. By Indication
  • 6.1.3. By Form
  • 6.1.4. By Region
• 6.2. 2021 Market Scenario

7. Global Eye Health Products Market Demand Outlook, 2019 - 2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
• 7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Eye Health Products Market Outlook, 2019 - 2032

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis, by Ingredient, 2019-2024
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Ingredient, 2025-2032
  • 8.3.1. Lutein and Zeaxanthin
  • 8.3.2. Antioxidants
  • 8.3.3. Omega-3 Fatty Acids
  • 8.3.4. Coenzyme Q10
  • 8.3.5. Flavonoids
  • 8.3.6. Astaxanthin
  • 8.3.7. Alpha-Lipoic Acid
  • 8.3.8. Other Ingredients
• 8.4. Market Attractiveness Analysis, by Ingredient

9. Global Eye Health Products Market Outlook, 2019 - 2032

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2024
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Indication, 2025-2032
  • 9.3.1. Age-related Macular Degeneration (AMD)
  • 9.3.2. Cataract
  • 9.3.3. Dry Eye Syndrome
  • 9.3.4. Other Indications
• 9.4. Market Attractiveness Analysis, by Indication

10. Global Eye Health Products Market Outlook, 2019 - 2032

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis, By Form, 2019-2024
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Form, 2025-2032
  • 10.3.1. Tablet
  • 10.3.2. Capsule
  • 10.3.3. Others
• 10.4. Market Attractiveness Analysis, by Form

11. Global Eye Health Products Market Outlook, 2019 - 2032

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2024
• 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis, by Region

12. North America Eye Health Products Market Outlook, 2019 - 2032

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
• 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Ingredient
  • 12.3.3. By Indication
  • 12.3.4. By Form
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Ingredient
  • 12.4.3. By Indication
  • 12.4.4. By Form
• 12.5. Market Trends
• 12.6. Drivers and Restraints - Impact Analysis
• 12.7. Country Level Analysis & Forecast
  • 12.7.1. U.S. Eye Health Products Market Analysis
    • 12.7.1.1. Introduction
    • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 12.7.1.2.1. By Ingredient
      • 12.7.1.2.2. By Indication
      • 12.7.1.2.3. By Form
  • 12.7.2. Canada Eye Health Products Market Analysis
    • 12.7.2.1. Introduction
    • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 12.7.2.2.1. By Ingredient
      • 12.7.2.2.2. By Indication
      • 12.7.2.2.3. By Form

13. Latin America Eye Health Products Market Outlook, 2019 - 2032

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
• 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 13.3.1. By Country
    • 13.3.1.1. Mexico
    • 13.3.1.2. Brazil
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Ingredient
  • 13.3.3. By Indication
  • 13.3.4. By Form
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Ingredient
  • 13.4.3. By Indication
  • 13.4.4. By Form
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Country Level Analysis & Forecast
  • 13.7.1. Mexico Eye Health Products Market Analysis
    • 13.7.1.1. Introduction
    • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.7.1.2.1. By Ingredient
      • 13.7.1.2.2. By Indication
      • 13.7.1.2.3. By Form
  • 13.7.2. Brazil Eye Health Products Market Analysis
    • 13.7.2.1. Introduction
    • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.7.2.2.1. By Ingredient
      • 13.7.2.2.2. By Indication
      • 13.7.2.2.3. By Form
  • 13.7.3. Argentina Eye Health Products Market Analysis
    • 13.7.3.1. Introduction
    • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.7.3.2.1. By Ingredient
      • 13.7.3.2.2. By Indication
      • 13.7.3.2.3. By Form

14. Europe Eye Health Products Market Outlook, 2019-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
• 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Ingredient
  • 14.3.3. By Indication
  • 14.3.4. By Form
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Ingredient
  • 14.4.3. By Indication
  • 14.4.4. By Form
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Country Level Analysis & Forecast
  • 14.7.1. Germany Eye Health Products Market Analysis
    • 14.7.1.1. Introduction
    • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.1.2.1. By Ingredient
      • 14.7.1.2.2. By Indication
      • 14.7.1.2.3. By Form
  • 14.7.2. Italy Eye Health Products Market Analysis
    • 14.7.2.1. Introduction
    • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.2.2.1. By Ingredient
      • 14.7.2.2.2. By Indication
      • 14.7.2.2.3. By Form
  • 14.7.3. France Eye Health Products Market Analysis
    • 14.7.3.1. Introduction
    • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.3.2.1. By Ingredient
      • 14.7.3.2.2. By Indication
      • 14.7.3.2.3. By Form
  • 14.7.4. U.K. Eye Health Products Market Analysis
    • 14.7.4.1. Introduction
    • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.4.2.1. By Ingredient
      • 14.7.4.2.2. By Indication
      • 14.7.4.2.3. By Form
  • 14.7.5. Spain Eye Health Products Market Analysis
    • 14.7.5.1. Introduction
    • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.5.2.1. By Ingredient
      • 14.7.5.2.2. By Indication
      • 14.7.5.2.3. By Form
  • 14.7.6. BENELUX Eye Health Products Market Analysis
    • 14.7.6.1. Introduction
    • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.6.2.1. By Ingredient
      • 14.7.6.2.2. By Indication
      • 14.7.6.2.3. By Form
  • 14.7.7. Russia Eye Health Products Market Analysis
    • 14.7.7.1. Introduction
    • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.7.7.2.1. By Ingredient
      • 14.7.7.2.2. By Indication
      • 14.7.7.2.3. By Form

15. East Asia Eye Health Products Market Outlook, 2019 - 2032

• 15.1. Introduction
• 15.2. Historical Market Form (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
• 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Ingredient
  • 15.3.3. By Indication
  • 15.3.4. By Form
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Ingredient
  • 15.4.2. By Indication
  • 15.4.3. By Form
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Country Level Analysis & Forecast
  • 15.7.1. China Eye Health Products Market Analysis
    • 15.7.1.1. Introduction
    • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.1.2.1. By Ingredient
      • 15.7.1.2.2. By Indication
      • 15.7.1.2.3. By Form
  • 15.7.2. Japan Eye Health Products Market Analysis
    • 15.7.2.1. Introduction
    • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.2.2.1. By Ingredient
      • 15.7.2.2.2. By Indication
      • 15.7.2.2.3. By Form
  • 15.7.3. South Korea Eye Health Products Market Analysis
    • 15.7.3.1. Introduction
    • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.7.3.2.1. By Ingredient
      • 15.7.3.2.2. By Indication
      • 15.7.3.2.3. By Form

16. South Asia Eye Health Products Market Outlook, 2019-2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
• 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Ingredient
  • 16.3.3. By Indication
  • 16.3.4. By Form
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Ingredient
  • 16.4.3. By Indication
  • 16.4.4. By Form
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Country Level Analysis & Forecast
  • 16.7.1. India Eye Health Products Market Analysis
    • 16.7.1.1. Introduction
    • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.7.1.2.1. By Ingredient
      • 16.7.1.2.2. By Indication
      • 16.7.1.2.3. By Form
  • 16.7.2. Indonesia Eye Health Products Market Analysis
    • 16.7.2.1. Introduction
    • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.7.2.2.1. By Ingredient
      • 16.7.2.2.2. By Indication
      • 16.7.2.2.3. By Form
  • 16.7.3. Malaysia Eye Health Products Market Analysis
    • 16.7.3.1. Introduction
    • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.7.3.2.1. By Ingredient
      • 16.7.3.2.2. By Indication
      • 16.7.3.2.3. By Form
  • 16.7.4. Thailand Eye Health Products Market Analysis
    • 16.7.4.1. Introduction
    • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.7.4.2.1. By Ingredient
      • 16.7.4.2.2. By Indication
      • 16.7.4.2.3. By Form

17. Oceania Eye Health Products Market Outlook, 2019 - 2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
• 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Ingredient
  • 17.3.3. By Indication
  • 17.3.4. By Form
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Ingredient
  • 17.4.3. By Indication
  • 17.4.4. By Form
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Country Level Analysis & Forecast
  • 17.7.1. Australia Eye Health Products Market Analysis
    • 17.7.1.1. Introduction
    • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.7.1.2.1. By Ingredient
      • 17.7.1.2.2. By Indication
      • 17.7.1.2.3. By Form
  • 17.7.2. New Zealand Eye Health Products Market Analysis
    • 17.7.2.1. Introduction
    • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.7.2.2.1. By Ingredient
      • 17.7.2.2.2. By Indication
      • 17.7.2.2.3. By Form

18. Middle East and Africa (MEA) Eye Health Products Market Outlook, 2019 - 2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2019-2024
• 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2025-2032
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkey
    • 18.3.1.3. South Africa
    • 18.3.1.4. North Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Ingredient
  • 18.3.3. By Indication
  • 18.3.4. By Form
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Ingredient
  • 18.4.2. By Indication
  • 18.4.3. By Form
• 18.5. Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Country Level Analysis & Forecast
  • 18.7.1. GCC Countries Eye Health Products Market Analysis
    • 18.7.1.1. Introduction
    • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.7.1.2.1. By Ingredient
      • 18.7.1.2.2. By Indication
      • 18.7.1.2.3. By Form
  • 18.7.2. Turkey Eye Health Products Market Analysis
    • 18.7.2.1. Introduction
    • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.7.2.2.1. By Ingredient
      • 18.7.2.2.2. By Indication
      • 18.7.2.2.3. By Form
  • 18.7.3. South Africa Eye Health Products Market Analysis
    • 18.7.3.1. Introduction
    • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.7.3.2.1. By Ingredient
      • 18.7.3.2.2. By Indication
      • 18.7.3.2.3. By Form
  • 18.7.4. North Africa Eye Health Products Market Analysis
    • 18.7.4.1. Introduction
    • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.7.4.2.1. By Ingredient
      • 18.7.4.2.2. By Indication
      • 18.7.4.2.3. By Form

19. Market Structure Analysis

• 19.1. Market Analysis, by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Competition Benchmarking
• 20.3. Competition Deep Dive
  • 20.3.1. Pfizer Inc.
    • 20.3.1.1. Overview
    • 20.3.1.2. Ingredient Portfolio
    • 20.3.1.3. Sales Footprint
    • 20.3.1.4. Key Financials
    • 20.3.1.5. SWOT Analysis
    • 20.3.1.6. Strategy Overview
      • 20.3.1.6.1. Marketing Strategy
      • 20.3.1.6.2. Ingredient Strategy
      • 20.3.1.6.3. Channel Strategy
  • 20.3.2. The Nature's Bounty Co.
    • 20.3.2.1. Overview
    • 20.3.2.2. Ingredient Portfolio
    • 20.3.2.3. Sales Footprint
    • 20.3.2.4. Key Financials
    • 20.3.2.5. SWOT Analysis
    • 20.3.2.6. Strategy Overview
      • 20.3.2.6.1. Marketing Strategy
      • 20.3.2.6.2. Ingredient Strategy
      • 20.3.2.6.3. Channel Strategy
  • 20.3.3. Amway International
    • 20.3.3.1. Overview
    • 20.3.3.2. Ingredient Portfolio
    • 20.3.3.3. Sales Footprint
    • 20.3.3.4. Key Financials
    • 20.3.3.5. SWOT Analysis
    • 20.3.3.6. Strategy Overview
      • 20.3.3.6.1. Marketing Strategy
      • 20.3.3.6.2. Ingredient Strategy
      • 20.3.3.6.3. Channel Strategy
  • 20.3.4. Bausch + Lomb
    • 20.3.4.1. Overview
    • 20.3.4.2. Ingredient Portfolio
    • 20.3.4.3. Sales Footprint
    • 20.3.4.4. Key Financials
    • 20.3.4.5. SWOT Analysis
    • 20.3.4.6. Strategy Overview
      • 20.3.4.6.1. Marketing Strategy
      • 20.3.4.6.2. Ingredient Strategy
      • 20.3.4.6.3. Channel Strategy
  • 20.3.5. Nutrivein
    • 20.3.5.1. Overview
    • 20.3.5.2. Ingredient Portfolio
    • 20.3.5.3. Sales Footprint
    • 20.3.5.4. Key Financials
    • 20.3.5.5. SWOT Analysis
    • 20.3.5.6. Strategy Overview
      • 20.3.5.6.1. Marketing Strategy
      • 20.3.5.6.2. Ingredient Strategy
      • 20.3.5.6.3. Channel Strategy
  • 20.3.6. ZeaVision LLC
    • 20.3.6.1. Overview
    • 20.3.6.2. Ingredient Portfolio
    • 20.3.6.3. Sales Footprint
    • 20.3.6.4. Key Financials
    • 20.3.6.5. SWOT Analysis
    • 20.3.6.6. Strategy Overview
      • 20.3.6.6.1. Marketing Strategy
      • 20.3.6.6.2. Ingredient Strategy
      • 20.3.6.6.3. Channel Strategy
  • 20.3.7. Kemin Industries, Inc.
    • 20.3.7.1. Overview
    • 20.3.7.2. Ingredient Portfolio
    • 20.3.7.3. Sales Footprint
    • 20.3.7.4. Key Financials
    • 20.3.7.5. SWOT Analysis
    • 20.3.7.6. Strategy Overview
      • 20.3.7.6.1. Marketing Strategy
      • 20.3.7.6.2. Ingredient Strategy
      • 20.3.7.6.3. Channel Strategy
  • 20.3.8. EyeScience
    • 20.3.8.1. Overview
    • 20.3.8.2. Ingredient Portfolio
    • 20.3.8.3. Sales Footprint
    • 20.3.8.4. Key Financials
    • 20.3.8.5. SWOT Analysis
    • 20.3.8.6. Strategy Overview
      • 20.3.8.6.1. Marketing Strategy
      • 20.3.8.6.2. Ingredient Strategy
      • 20.3.8.6.3. Channel Strategy
  • 20.3.9. Nutrachamps
    • 20.3.9.1. Overview
    • 20.3.9.2. Ingredient Portfolio
    • 20.3.9.3. Sales Footprint
    • 20.3.9.4. Key Financials
    • 20.3.9.5. SWOT Analysis
    • 20.3.9.6. Strategy Overview
      • 20.3.9.6.1. Marketing Strategy
      • 20.3.9.6.2. Ingredient Strategy
      • 20.3.9.6.3. Channel Strategy
  • 20.3.10. Bausch Health Companies Inc.
    • 20.3.10.1. Overview
    • 20.3.10.2. Ingredient Portfolio
    • 20.3.10.3. Sales Footprint
    • 20.3.10.4. Key Financials
    • 20.3.10.5. SWOT Analysis
    • 20.3.10.6. Strategy Overview
      • 20.3.10.6.1. Marketing Strategy
      • 20.3.10.6.2. Ingredient Strategy
      • 20.3.10.6.3. Channel Strategy
  • 20.3.11. Vitabiotics Ltd.
    • 20.3.11.1. Overview
    • 20.3.11.2. Ingredient Portfolio
    • 20.3.11.3. Sales Footprint
    • 20.3.11.4. Key Financials
    • 20.3.11.5. SWOT Analysis
    • 20.3.11.6. Strategy Overview
      • 20.3.11.6.1. Marketing Strategy
      • 20.3.11.6.2. Ingredient Strategy
      • 20.3.11.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

관련자료